TD Waterhouse Canada’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $461K | Buy |
2,075
+41
| +2% | +$9.12K | ﹤0.01% | 673 |
|
|
2025
Q1 | $448K | Sell |
2,034
-207
| -9% | -$45.6K | ﹤0.01% | 652 |
|
|
2024
Q4 | $734K | Buy |
2,241
+347
| +18% | +$114K | 0.01% | 558 |
|
|
2024
Q3 | $567K | Sell |
1,894
-2,662
| -58% | -$797K | ﹤0.01% | 594 |
|
|
2024
Q2 | $1.48M | Sell |
4,556
-171
| -4% | -$55.5K | 0.01% | 419 |
|
|
2024
Q1 | $1.88M | Buy |
4,727
+461
| +11% | +$183K | 0.01% | 400 |
|
|
2023
Q4 | $1.49M | Buy |
4,266
+144
| +3% | +$50.2K | 0.01% | 366 |
|
|
2023
Q3 | $1.56M | Buy |
4,122
+1,535
| +59% | +$581K | 0.02% | 351 |
|
|
2023
Q2 | $1M | Buy |
2,587
+32
| +1% | +$12.4K | 0.01% | 412 |
|
|
2023
Q1 | $907K | Buy |
2,555
+1,393
| +120% | +$495K | 0.01% | 429 |
|
|
2022
Q4 | $274K | Buy |
1,162
+364
| +46% | +$85.7K | ﹤0.01% | 609 |
|
|
2022
Q3 | $205K | Buy |
798
+344
| +76% | +$88.3K | ﹤0.01% | 665 |
|
|
2022
Q2 | $141K | Buy |
454
+442
| +3,683% | +$137K | ﹤0.01% | 732 |
|
|
2022
Q1 | $5K | Sell |
12
-7,334
| -100% | -$3.05M | ﹤0.01% | 1449 |
|
|
2021
Q4 | $3.83M | Buy |
+7,346
| New | +$3.83M | 0.04% | 253 |
|